Investing.com - Financial Markets Worldwide
Get 40% Off
Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

OpGen Inc (OPGN)

NASDAQ
Symbol
Exchange
Currency
OPGNNASDAQUSD
0A8LLondonUSD
Currency in USD
Disclaimer
0.563
-0.050(-8.16%)
Closed
After Hours
0.580+0.017(+3.055%)

OPGN Comments

Time for a dollar play.
run run sell out , i love 60k with Curetis when they tie up merger with OpGen ...pity , i advise as a friend to friend sell out before to be late.
We’ll be surprised that one morning this stock will fly to the moon.🥂
Following successful completion of Phase 1, Ares Genetics has now entered into Phase 2 of its collaboration with a leading U.S. CRO and reference lab, gaining access to 1,000 proprietary clinical isolates from key pathogensARESdb contents has grown by more than 40% in a yearROCKVILLE, Md., Dec. 14, 2021 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen” or the “Company”), a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease, announced today that its subsidiary, Ares Genetics (Ares), has successfully completed Phase 1 of its collaboration with a leading U.S. CRO and reference lab, originally announced in August. During Phase 2, Ares will gain access to 1,000 proprietary genome and AST datasets thereby strategically enriching ARESdb with proprietary data for key pathogens.Antimicrobial resistance (AMR) is a growing threat to public health believed to be causing 700,000 fatalities globally each year and bill
to the moon
This is worse than pump and dump. I will in if this will reach at 0.99/share
can anyone tell me why this is abl buy
Hodling with diamonds.
Yeah they want us to sell so when the price is dip those manipulators will buy.😀. So, I would say, let them down the price, don’t buy for now. Just wait, if they want it at the very low price then let it be. Don’t buy and don’t sell either. 💪💪
Manipulation by short hedge funds. No worries.
gonna 🚀 fir Thursday-Frfiday premarget, and then this will get to high 4's, at least. buyin more.
This gonna be a nice Pop if they try n short this. Ima buy more at 2.80! From there POW 🎉🚀
Buy more, it will go up this week.
Im wit u
got in @3,1 Tarvet 12$
tarGet
Now it will tripple. Fda approval
$4 today? then $6 next week?
sell
and why ?
$OPGN looking to make a run to $5 as cash on hand triples from q4 with expected fda clearance this quarter for amr gene panel. Load the boat!!! Check due diligence post on wallstreetbets. A runner that will run like a stealth under the radar!  https://www.reddit.com/r/stocks/comments/lgkvca/opgn_to_the_moon/?utm_source=share&utm_medium=ios_app&utm_name=iossmf
$20!
when
fraud company i lost my half money with their partners Curetis NV they stole our  money , they will do the same OPGN with you one day they will bankrupt too. Last year bankrupt their partners in Europe in Germany . Look the history before to loose your sweet money.!
To the moon pls 🚀🚀
Finally some movements ........
crap stock...
🐇
Could it possibly reach 10?
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.